Atlas Trials

Reverse Transcriptase Inhibitors in AGS

Clinical trial NCT02363452 · COMPLETED

Trial details

NCT number
NCT02363452
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aicardi-Goutières Syndrome (AGS)
Start date
2015-09-10
Primary completion
2018-01-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.